Skip to main content
Clinical Trials/ACTRN12614001263684
ACTRN12614001263684
Active, not recruiting
Phase 3

In newborn infants at risk of hypoglycaemia does prophylactic oral dextrose gel compared to placebo reduce admission to Newborn Intensive Care Unit (NICU).

niversity of Auckland0 sites2,149 target enrollmentDecember 3, 2014

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
eonatal Hypoglycaemia
Sponsor
niversity of Auckland
Enrollment
2149
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 3, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Babies who are at risk of hypoglycaemia, defined as satisfying AT LEAST ONE of the following:
  • 1\. Infants of diabetic mothers (any type of diabetes)
  • 2\. Preterm (\< 37 weeks' gestation)
  • 3\. Small (\< 2\.5kg or \< 10th centile on population or customised birthweight chart)
  • 4\. Large (\> 4\.5kg or \> 90th centile on population or customised birthweight chart)
  • AND satisfy ALL of the following:
  • 1\. \> or \= 35\+0 weeks' gestation
  • 2\. Birthweight \> or \= 2\.2kg
  • 3\. \< 1 hour old
  • 4\. No apparent indication for NICU/SCBU admission at time of randomisation

Exclusion Criteria

  • 1\. Major congenital abnormality
  • 2\. Previous formula feed or intravenous fluids
  • 3\. Previous diagnosis of hypoglycaemia
  • 4\. Admitted to NICU/SCBU
  • 5\. Imminent admission to NICU/SCB

Outcomes

Primary Outcomes

Not specified

Similar Trials